Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Assets Average (2020 - 2025)

Ovid Therapeutics (OVID) has disclosed Assets Average for 6 consecutive years, with $70.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average fell 36.0% year-over-year to $70.6 million, compared with a TTM value of $70.6 million through Sep 2025, down 36.0%, and an annual FY2024 reading of $118.1 million, down 21.08% over the prior year.
  • Assets Average was $70.6 million for Q3 2025 at Ovid Therapeutics, down from $79.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $227.7 million in Q2 2021 and bottomed at $70.6 million in Q3 2025.
  • Average Assets Average over 5 years is $145.7 million, with a median of $139.8 million recorded in 2023.
  • The sharpest move saw Assets Average skyrocketed 325.35% in 2021, then plummeted 36.94% in 2025.
  • Year by year, Assets Average stood at $200.8 million in 2021, then decreased by 20.25% to $160.1 million in 2022, then fell by 16.0% to $134.5 million in 2023, then dropped by 27.59% to $97.4 million in 2024, then fell by 27.48% to $70.6 million in 2025.
  • Business Quant data shows Assets Average for OVID at $70.6 million in Q3 2025, $79.5 million in Q2 2025, and $86.9 million in Q1 2025.